study objective : to determine whether trisodium phosphonoformate ( foscarnet ) is efficacious in treating severe mucocutaneous disease due to acyclovir-resistant herpes simplex virus type-2 ( hsv-2 ) infection in patients with the acquired immunodeficiency syndrome ( aids ) .
C0146934
trisodium phosphonoformate
C0070895
foscarnet